Y. Yáñez Castillo

Conductive hyperthermic chemotherapy versus electromotive drug administration of mitomycin C as intravesical adjuvant treatment of patients with intermediate or high-risk non-muscle invasive bladder cancer.

M. Arrabal Martín, M. A. Arrabal Polo, M. Pareja Vílchez, 2022, Urologic oncology.

Adjuvant intravesical treatment in patients with intermediate and high-risk non-muscle-invasive bladder cancer with BCG versus MMC applied with COMBAT or EMDA. Results of a prospective study

M. Arrabal Martín, M. A. Arrabal Polo, M. Pareja Vílchez, 2023, Journal of Cancer Research and Clinical Oncology.

Allium stent placement after ureteral avulsion repair

M. Arrabal Martín, A. Jiménez Pacheco, M. T. Melgarejo Segura, 2022, International Urology and Nephrology.

Electromotive Drug Administration Chemotherapy with Mitomycin C Versus Bacillus Calmette-Guerin for the Treatment of Non-Muscle Invasive Bladder Cancer

M. Arrabal Martín, M. A. Arrabal Polo, M. Pareja Vílchez, 2023, Bladder Cancer.

Efficacy of conduction hyperthermia in the treatment of non-muscle invasive bladder cancer: A systematic review.

M. A. Arrabal Polo, M. T. Melgarejo Segura, A. Morales Martínez, 2024, Urologic oncology.